Literature DB >> 21093885

Review and update of involuntary facial movement disorders presenting in the ophthalmological setting.

Adam H Ross1, John S Elston, Marie-Helene Marion, Raman Malhotra.   

Abstract

We review the existing literature on the involuntary facial movement disorders-benign essential blepharospasm, apraxia of eyelid opening, hemifacial spasm, and aberrant facial nerve regeneration. The etiology of idiopathic blepharospasm, a disorder of the central nervous system, and hemifacial spasm, a condition involving the facial nerve of the peripheral nervous system, is markedly different. We discuss established methods of managing patients and highlight new approaches.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21093885     DOI: 10.1016/j.survophthal.2010.03.008

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  10 in total

1.  [Botulinum toxin for ocular complications after facial palsy].

Authors:  E Torres Suárez
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

2.  Use of Botulinum Toxin in Ophthalmology.

Authors:  Michael J Wan; Sara AlShaker; David G Hunter
Journal:  Handb Exp Pharmacol       Date:  2021

3.  A trial of a mechanical device for the treatment of blepharospasm.

Authors:  Alexina Fantato; Manoj Parulekar; John Elston
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

4.  Criteria for the diagnosis of corticobasal degeneration.

Authors:  Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner
Journal:  Neurology       Date:  2013-01-29       Impact factor: 9.910

5.  Analysis of blink activity and anomalous eyelid movements in patients with hemifacial spasm.

Authors:  Midori H Osaki; Tammy H Osaki; Denny M Garcia; Teissy Osaki; Gustavo R Gameiro; Rubens Belfort; Antonio Augusto V Cruz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-20       Impact factor: 3.117

6.  Clinical Features of Benign Essential Blepharospasm in Korean Patients.

Authors:  Jeong Min Lee; Ji Sun Baek; Hye Sun Choi; Sung Joo Kim; Jae Woo Jang
Journal:  Korean J Ophthalmol       Date:  2018-10

7.  Eyelid Myokymia-a Presumed Manifestation of Coronavirus Disease 2019 (COVID-19).

Authors:  Hashim Ali Khan; Muhammad Aamir Shahzad; Smaha Jahangir; Junaid Iqbal; Suhail Abbas Juwa; Qaim Ali Khan; Naeemullah Khan; Muhammad Afzal; Fatima Iqbal
Journal:  SN Compr Clin Med       Date:  2022-01-10

Review 8.  Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm.

Authors:  Khashayar Dashtipour; Jack J Chen; Karen Frei; Fatta Nahab; Michele Tagliati
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-10-30

9.  Topiramate-Induced Persistent Eyelid Myokymia.

Authors:  Mohammadrasoul Khalkhali
Journal:  Case Rep Psychiatry       Date:  2016-05-17

10.  Facial Weakness, Otalgia, and Hemifacial Spasm: A Novel Neurological Syndrome in a Case-Series of 3 Patients With Rheumatic Disease.

Authors:  Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.